Valeant CEO forced to sell shares to repay $100M loan
New York Post-Nov 6, 2015
Valeant is under scrutiny over how it prices and distributes drugs, in particular its relationship with a specialty pharmacy Philidor. Lawmakers and regulators are ...
No comments:
Post a Comment